The Russian government plans to provide compensations for the local drugmakers, specializing on the design and production of cheap and middle-priced drugs, which suffered through the current economic crisis in Russia, caused by Western sanctions, according to recent statements of Russia’s Prime Minister Dmitry Medvedev.
According to Mr Medvedev, the exact amount of compensations has not yet been defined. He added that the majority of producers hope for 80% indexation, however a final decision has not been taken. According to some sources in the Russian Ministry of Health, the amount of indexation will not exceed 30%, reports The Pharma Letter’s local correspondent.
According to state data, prices for drugs from cheap and middle-priced range since the beginning of the current year have increased by 20% but, according to data from some local analysts, these figures are significantly higher.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze